Business Description
Regencell Bioscience Holdings Ltd
ISIN : KYG7487R1002
Total Employee Number:
10Description
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 8.99 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.45 | |||||
Debt-to-EBITDA | -0.08 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 20.6 | |||||
3-Year EPS without NRI Growth Rate | 22.4 | |||||
3-Year FCF Growth Rate | 16.4 | |||||
3-Year Book Growth Rate | -34.1 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 6.01 | |||||
9-Day RSI | 9.7 | |||||
14-Day RSI | 14.94 | |||||
3-1 Month Momentum % | -4.29 | |||||
6-1 Month Momentum % | 14.89 | |||||
12-1 Month Momentum % | 20.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -0.01 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -165.29 | |||||
ROA % | -130.15 | |||||
ROIC % | -183.53 | |||||
3-Year ROIIC % | -469.84 | |||||
ROC (Joel Greenblatt) % | -220.51 | |||||
ROCE % | -137.29 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -448.67 | |||||
EV-to-EBITDA | -448.67 | |||||
EV-to-FCF | -979.47 | |||||
| Price-to-Net-Current-Asset-Value | 635.5 | |||||
| Price-to-Net-Cash | 635.5 | |||||
Earnings Yield (Greenblatt) % | -0.22 | |||||
FCF Yield % | -0.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RGC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Regencell Bioscience Holdings Ltd Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.015 | ||
| Beta | 1.2651 | ||
| 3-Year Sharpe Ratio | 0.8 | ||
| 3-Year Sortino Ratio | 12.12 | ||
| Volatility % | 103.72 | ||
| 14-Day RSI | 14.94 | ||
| 14-Day ATR ($) | 2.24218 | ||
| 20-Day SMA ($) | 17.12425 | ||
| 12-1 Month Momentum % | 20.41 | ||
| 52-Week Range ($) | 5.8 - 69 | ||
| Shares Outstanding (Mil) | 494.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Regencell Bioscience Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Regencell Bioscience Holdings Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2026-10-30 | In 125 days | ||
| General meeting for 2025 | 2026-06-30 | In 3 days | ||
| Second quarter earnings results for 2026 | 2026-06-30 | In 3 days | ||
| Annual report for 2025 | 2025-10-31 | 16.35 (+0.74%) | ||
| 38:1 Stock Split | 2025-06-16 | 15.66 (-5.22%) | ||
| Annual report for 2024 | 2024-10-25 | 0.12 (-1.51%) |
Show
Entries
Regencell Bioscience Holdings Ltd Frequently Asked Questions
What is Regencell Bioscience Holdings Ltd(RGC)'s stock price today?
The current price of RGC is $6.36. The 52 week high of RGC is $69.00 and 52 week low is $5.80.
When is next earnings date of Regencell Bioscience Holdings Ltd(RGC)?
The next earnings date of Regencell Bioscience Holdings Ltd(RGC) is 2026-06-30 Est..
Does Regencell Bioscience Holdings Ltd(RGC) pay dividends? If so, how much?
Regencell Bioscience Holdings Ltd(RGC) does not pay dividend.
Guru Commentaries on NAS:RGC
No articles.
Press Release
Articles on Regencell Bioscience Holdings Ltd
No articles.
Headlines
See More- 1
Jun 13, 2026
RGC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
Benzinga • 7:20am
Jun 05, 2026
Jun 04, 2026
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers